After CDC approval to vaccinate children 6 months to 5 years of age, 4-year-old Eleanor Kahn sits with her father Alex, as a nurse, Jillian Mercer gives Moderna vaccine for coronavirus disease (COVID-19) at the San Diego Council Children’s Hospital, California, USA, June 21, 2022
Mike Blake | Reuters
Moderna has asked the Food and Drug Administration to authorize omicron booster injections for children, the company said on Friday.
Moderna has filed two separate applications for FDA authorization, one for adolescents 12 to 17 years of age and one for children 6 to 11 years of age. -old, still this year.
The Centers for Disease Control and Prevention, in a document released on Tuesday, said it expected children to qualify for omicron booster doses by mid-October pending FDA approval. The CDC’s Advisory Committee on Vaccines has meetings scheduled for October 19-20.
Pfizer told the CDC’s advisory committee earlier this month that it expects to ask the FDA for approval of omicron booster doses for children 5 to 11 years of age in early October.
Earlier this month, U.S. health regulators approved Moderna’s adult omicron boosters. Pfizer legal highs were authorized for people aged 12 and over.
The new injections are targeting the omicron BA.5 sub-variant as well as the original Covid strain that first appeared in China in late 2019. The FDA and CDC expect the new booster doses to provide better protection against infection and disease as they target the most common omicron sub-variant.
Old vaccines that were designed to combat the original Covid strain no longer provide significant protection against infection and mild disease because the virus has mutated so much. There is also concern that the effectiveness of the original injections in preventing hospitalization and severe disease is starting to decline.
Public health officials are confident of the new omicron BA.5 boosters, although it is unclear how effective they will be in the real world. The shots were approved without human clinical trial data